Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Almased on Glycemic Control and Metabolic Effects in Patients With Type 2 Diabetes

NCT01702012 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT01702012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01702012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Almased on Glycemic Control and Metabolic Effects in Patients With Type 2 Diabetes
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
May 31, 2015
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, type 2 diabetes